PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Laboratory of RNA Epigenetics, Institutes of Biomedical Sciences & Shanghai Public Health Clinical Center & Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute Shanghai Medical College, Fudan University, Shanghai, P. R. China.\', \'Shanghai Public Health Clinical Center, Fudan University, Shanghai, P. R. China.\', \'Department of Radiology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, P. R. China.\', \'Zhongshan Hospital, Fudan University, Shanghai, P. R. China.\', \'Department of Radiology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, P. R. China. shanfei@shphc.org.cn.\', \'Laboratory of RNA Epigenetics, Institutes of Biomedical Sciences & Shanghai Public Health Clinical Center & Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute Shanghai Medical College, Fudan University, Shanghai, P. R. China. wenqiangyu@fudan.edu.cn.\', \'Shanghai Public Health Clinical Center, Fudan University, Shanghai, P. R. China. luhongzhou@fudan.edu.cn.\', \'The Third People\'s Hospital of Shenzhen, Shenzhen, P. R. China. luhongzhou@fudan.edu.cn.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41392-022-00952-w
?:doi
?:hasPublicationType
?:journal
  • Signal transduction and targeted therapy
is ?:pmid of
?:pmid
?:pmid
  • 35304437
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Hymecromone: a clinical prescription hyaluronan inhibitor for efficiently blocking COVID-19 progression.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all